Literature DB >> 35724659

Rational domestication of a plant-based recombinant expression system expands its biosynthetic range.

Mark A Jackson1, Lai Yue Chan1, Maxim D Harding1, David J Craik1, Edward K Gilding1.   

Abstract

Plant molecular farming aims to provide a green, flexible, and rapid alternative to conventional recombinant expression systems, capable of producing complex biologics such as enzymes, vaccines, and antibodies. Historically, the recombinant expression of therapeutic peptides in plants has proven difficult, largely due to their small size and instability. However, some plant species harbour the capacity for peptide backbone cyclization, a feature inherent in stable therapeutic peptides. One obstacle to realizing the potential of plant-based therapeutic peptide production is the proteolysis of the precursor before it is matured into its final stabilized form. Here we demonstrate the rational domestication of Nicotiana benthamiana within two generations to endow this plant molecular farming host with an expanded repertoire of peptide sequence space. The in planta production of molecules including an insecticidal peptide, a prostate cancer therapeutic lead, and an orally active analgesic is demonstrated.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Experimental Biology.

Entities:  

Keywords:  Asparaginyl endopeptidase (AEP); CRISPR/Cas9; cyclotide; gene editing; insecticide; peptide; plant molecular farming; protease; recombinant; therapeutic

Mesh:

Substances:

Year:  2022        PMID: 35724659      PMCID: PMC9578353          DOI: 10.1093/jxb/erac273

Source DB:  PubMed          Journal:  J Exp Bot        ISSN: 0022-0957            Impact factor:   7.298


  61 in total

1.  High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds.

Authors:  S Luckett; R S Garcia; J J Barker; A V Konarev; P R Shewry; A R Clarke; R L Brady
Journal:  J Mol Biol       Date:  1999-07-09       Impact factor: 5.469

2.  Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds.

Authors:  Lai Y Chan; Sunithi Gunasekera; Sonia T Henriques; Nathalie F Worth; Sarah-Jane Le; Richard J Clark; Julie H Campbell; David J Craik; Norelle L Daly
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

3.  Designing macrocyclic disulfide-rich peptides for biotechnological applications.

Authors:  Conan K Wang; David J Craik
Journal:  Nat Chem Biol       Date:  2018-04-16       Impact factor: 15.040

Review 4.  Viral contamination in biologic manufacture and implications for emerging therapies.

Authors:  Paul W Barone; Michael E Wiebe; James C Leung; Islam T M Hussein; Flora J Keumurian; James Bouressa; Audrey Brussel; Dayue Chen; Ming Chong; Houman Dehghani; Lionel Gerentes; James Gilbert; Dan Gold; Robert Kiss; Thomas R Kreil; René Labatut; Yuling Li; Jürgen Müllberg; Laurent Mallet; Christian Menzel; Mark Moody; Serge Monpoeho; Marie Murphy; Mark Plavsic; Nathan J Roth; David Roush; Michael Ruffing; Richard Schicho; Richard Snyder; Daniel Stark; Chun Zhang; Jacqueline Wolfrum; Anthony J Sinskey; Stacy L Springs
Journal:  Nat Biotechnol       Date:  2020-04-27       Impact factor: 54.908

Review 5.  The Rise and Rise of Nicotiana benthamiana: A Plant for All Reasons.

Authors:  Julia Bally; Hyungtaek Jung; Cara Mortimer; Fatima Naim; Joshua G Philips; Roger Hellens; Aureliano Bombarely; Michael M Goodin; Peter M Waterhouse
Journal:  Annu Rev Phytopathol       Date:  2018-08-25       Impact factor: 13.078

6.  Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.

Authors:  Brian J Ward; Philipe Gobeil; Annie Séguin; Judith Atkins; Iohann Boulay; Pierre-Yves Charbonneau; Manon Couture; Marc-André D'Aoust; Jiwanjeet Dhaliwall; Carolyn Finkle; Karen Hager; Asif Mahmood; Alexander Makarkov; Matthew P Cheng; Stéphane Pillet; Patricia Schimke; Sylvie St-Martin; Sonia Trépanier; Nathalie Landry
Journal:  Nat Med       Date:  2021-05-18       Impact factor: 53.440

7.  A high-throughput peptidomic strategy to decipher the molecular diversity of cyclic cysteine-rich peptides.

Authors:  Aida Serra; Xinya Hemu; Giang K T Nguyen; Ngan T K Nguyen; Siu Kwan Sze; James P Tam
Journal:  Sci Rep       Date:  2016-03-11       Impact factor: 4.379

8.  Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy.

Authors:  Lai Yue Chan; David J Craik; Norelle L Daly
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

9.  Rapid and Scalable Plant-Based Production of a Potent Plasmin Inhibitor Peptide.

Authors:  Mark A Jackson; Kuok Yap; Aaron G Poth; Edward K Gilding; Joakim E Swedberg; Simon Poon; Haiou Qu; Thomas Durek; Karen Harris; Marilyn A Anderson; David J Craik
Journal:  Front Plant Sci       Date:  2019-05-15       Impact factor: 5.753

10.  Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity.

Authors:  Rajasekaran Ganesan; Mansour A Dughbaj; Lisa Ramirez; Steven Beringer; Teshome L Aboye; Alexander Shekhtman; Paul M Beringer; Julio A Camarero
Journal:  Chemistry       Date:  2021-08-06       Impact factor: 5.020

View more
  1 in total

1.  Rational domestication of a plant-based recombinant expression system expands its biosynthetic range.

Authors:  Mark A Jackson; Lai Yue Chan; Maxim D Harding; David J Craik; Edward K Gilding
Journal:  J Exp Bot       Date:  2022-10-18       Impact factor: 7.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.